Ibrunat 140 mg

Description

Ibrunat 140 mg

Ibrunat 140 mg (Ibrutinib) is designed to treat various types of cancer such as mantle cell lymphoma, chronic lymphocytic leukemia Waldenstrom’s macroglobulinemia. This medicine belongs to a group of drugs called kinase inhibitors. It helps to suppress the growth of cancerous cells.

Ibrunat 140 mg (Ibrutinib) is used after the primary detection of chronic lymphocytic leukemia. It improves blood cell count and decreases lymph nodes. The working principle of Ibrunat 140 mg (Ibrutinib) is by blocking the multiplication of abnormal protein growth that signals the cancer cell to multiply.

A doctor should advise this medicine and dosage. The capsules should be taken at a fixed time. This is a very powerful drug and should be consumed under the advice of a doctor. It has a lot of side effects and you should contact health care immediately if any symptoms surface.

• It is given in newly diagnosed blood cancer patient
• Helps in increasing healthy red blood cell count
• It’s given before the commencement of chemotherapy

Peculiar advantages of Ibrunat 140 mg (Ibrutinib)

• It keeps chronic leukemia under control
• Increases healthy red blood cells
• Decreases lymph nodes

In various clinical trials, this medicine showed impressive results. This medication showed positive effects on 88% of patients who had previous treatment and 86% who had this as first-line treatment.

Administration of Ibrunat 140 mg (Ibrutinib)

Ibrunat 140 mg (Ibrutinib) is available for treating patients above the age of 18 with chronic lymphocytic lymphoma who have received any treatment before or are in first-line treatment. It is to be taken daily at the same time with a glass of water.

The capsule is to be swallowed fully without chewing the tablet. The tablet is not to be cut in half and consumed. Any missed dose can be replaced as soon as possible on the same day.

It is advised not to take any extra dose to make up a previously missed dose.

Most common side effects of Ibrunat 140 mg (Ibrutinib)

• Dizziness
• Weakness
• Confusion
• Blabbering while talking
• Severe, long-lasting headaches
• Blood coughs
• Bloody vomit
• Infections can happen with the administration of Ibrunat 140 mg (Ibrutinib). If any symptoms like fever, chills, confusion, weakness surface, contact your health care provider right away
• Blood cell count may decrease (platelets, white blood cells, red blood cells) to keep this in check every month blood test should be done.
• People with risk of heart disease may find heart rhythm problems who have experienced heart-related problems earlier might contact their doctors if they see any abnormal symptoms. Symptoms like dizziness, shortness of breath, chest discomfort, or faint may be brought to notice to doctors immediately. The doctor may check your ECG and alternate the dose.
• Some people notice high blood pressure during medication. Your doctor may give you medicines to keep your blood pressure checked during this medication.
• Tumour lysis syndrome (TLS). TLS is a fast breakdown of cancer cells. This can eventually lead to kidney failure, irregular heartbeat, seizures, and sometimes death.

When should Ibrunat 140 mg (Ibrutinib) be avoided or used cautiously?

• If a patient is previously having complaint of heart-related problems
• If a person already has hypertension, one should have bp checked regularly
• If the patient is anemic, then one should use the medication cautiously

Most common side effects of Ibrunat 140 mg (Ibrutinib)

• Tiredness
• Heartburn
• Dizziness
• Irregular heartbeat
• Confusion
• Blood cough
• Bloody vomit
• Blabbering of speech

Laboratory side effects of Ibrunat 140 mg (Ibrutinib)

• Low levels of red blood cell count
• Increase in blood pressure
• Weakness due to lack of hemoglobin in the blood
• High levels of fat molecules (triglyceride), (hyperglycemia), cholesterol (hypercholesterolemia), and sugars (hyperglycemia)

Increased levels of proteins or enzymes like aspartate aminotransferase (AST), alanine aminotransferase (alt), and alkaline phosphate.

[/vc_column_text][/vc_column][/vc_row]